However, TGF-β which can be secreted by cancer-associated fibroblasts can trigger a SMAD- and YAP/TEAD-driven transcriptional program, leading to a downregulation of MITF expression as well as its target genes [100]. The gene discussed is MITF; the disease is cancer.